Skip to main content

Systemic Sclerosis Mimics

  • Chapter
  • First Online:

Abstract

Scleroderma-like or pseudo-scleroderma disorders are a wide group of diseases with various etiologies that lead to skin fibrosis therefore mimicking systemic sclerosis. Although they all have skin thickening in common, the distribution, pattern, and character of the involvement as well as systemic manifestations vary between them. The importance of recognizing these mimics resides in their different prognoses and treatment options. A complete clinical history, detailed physical exam as well as laboratory studies and skin biopsy can help differentiate them.

Since the list of scleroderma mimics is long, this chapter will focus on a few key disorders (eosinophilic fasciitis, scleredema, scleromyxedema, nephrogenic systemic fibrosis, diabetic cheiroarthropathy, and lipodermatosclerosis). Other rare conditions, such as metabolic diseases (phenylketonuria, porphyria cutanea tarda), exposure to chemical agents such as bleomycin, vinyl chloride, tryptophan and toxic oil syndrome, and genetic diseases such as progeria, Werner’s syndrome, and Stiff Man Syndrome, which can also cause skin sclerosis will not be discussed.

The absence of typical SSc features such as Raynaud’s phenomenon, antinuclear antibodies, and nailfold capillary changes should raise the index of suspicion for an alternative diagnosis.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Nashel J, Steen V. Scleroderma mimics. Curr Rheumatol Rep. 2012;14(1):39–46.

    Article  PubMed  Google Scholar 

  2. Boin F, Hummers LK. Scleroderma-like fibrosing disorders. Rheum Dis Clin North Am. 2008;34(1):199–220.

    Article  PubMed Central  PubMed  Google Scholar 

  3. Fujimoto M, Sato S, Ihn H, Kikuchi K, Yamada N, Takehara K. Serum aldolase level is a useful indicator of disease activity in eosinophilic fasciitis. J Rheumatol. 1995;22(3):563–5.

    CAS  PubMed  Google Scholar 

  4. Nashel J, Steen V. Elevation of aldolase in eosinophilic fasciitis. Arthritis Rheum. 2013;62(Suppl):S2011 (abstract).

    Google Scholar 

  5. Barnes L, Rodnan GP, Medsger TA, Short D. Eosinophilic fasciitis. A pathologic study of twenty cases. Am J Pathol. 1979;96(2):493–518.

    CAS  PubMed Central  PubMed  Google Scholar 

  6. Baumann F, Bruhlmann P, Andreisek G, Michel BA, Marincek B, Weishaupt D. MRI for diagnosis and monitoring of patients with eosinophilic fasciitis. AJR Am J Roentgenol. 2005;184(1):169–74.

    Article  PubMed  Google Scholar 

  7. Bischoff L, Derk CT. Eosinophilic fasciitis: demographics, disease pattern and response to treatment: report of 12 cases and review of the literature. Int J Dermatol. 2008;47(1):29–35.

    Article  PubMed  Google Scholar 

  8. Lebeaux D, Francès C, Barete S, Wechsler B, Dubourg O, Renoux J, Maisonobe T, Benveniste O, Gatfossé M, Bourgeois P, Amoura Z, Cacoub P, Piette JC, Sène D. Eosinophilic fasciitis (Shulman disease): new insights into the therapeutic management from a series of 34 patients. Rheumatology (Oxford). 2012;51(3):557–61.

    Article  CAS  Google Scholar 

  9. Beers WH, Ince A, Moore TL. Scleredema adultorum of Buschke: a case report and review of the literature. Semin Arthritis Rheum. 2006;35(6):355–9.

    Article  PubMed  Google Scholar 

  10. Rho YW, Suhr KB, Lee JH, Park JK. A clinical observation of scleredema adultorum and its relationship to diabetes. J Dermatol. 1998;25(2):103–7.

    CAS  PubMed  Google Scholar 

  11. Allam M, Ghozzi M. Scleromyxedema: a case report and review of the literature. Case Rep Dermatol. 2013;5(2):168–75. doi:10.1159/000353178.

    Article  PubMed Central  PubMed  Google Scholar 

  12. Gonzalez J, Palangio M, Schwartz J, Klainer AS, Bisaccia E. Scleromyxedema with dermato-neuro syndrome. J Am Acad Dermatol. 2000;42(5 Pt 2):927–8.

    Article  CAS  PubMed  Google Scholar 

  13. Blum M, Wigley FM, Hummers LK. Scleromyxedema: a case series highlighting long-term outcomes of treatment with intravenous immunoglobulin (IVIG). Medicine (Baltimore). 2008;87(1):10–20.

    Article  Google Scholar 

  14. Cowper SE, Rabach M, Girardi M. Clinical and histological findings in nephrogenic systemic fibrosis. Eur J Radiol. 2008;66(2):191–9.

    Article  PubMed  Google Scholar 

  15. Weller A, Barber JL, Olsen OE. Gadolinium and nephrogenic systemic fibrosis: an update. Pediatr Nephrol. 2013. [Epub ahead of print].

  16. Elmholdt TR, Buus NH, Ramsing M, Olesen AB. Antifibrotic effect after low-dose imatinib mesylate treatment in patients with nephrogenic systemic fibrosis: an open-label non-randomized, uncontrolled clinical trial. J Eur Acad Dermatol Venereol. 2013;27(6):779–84.

    Article  CAS  PubMed  Google Scholar 

  17. Abate M, Schiavone C, Salini V, Andia I. Management of limited joint mobility in diabetic patients. Diabetes Metab Syndr Obes. 2013;6:197–207.

    Article  PubMed Central  PubMed  Google Scholar 

  18. Miteva M, Romanelli P, Kirsner RS. Lipodermatosclerosis. Dermatol Ther. 2010;23(4):375–88.

    Article  PubMed  Google Scholar 

  19. Choonhakarn C, Chaowattanapanit S. Lipodermatosclerosis: improvement noted with hydroxychloroquine and pentoxifylline. J Am Acad Dermatol. 2012;66(6):1013–4.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Maureen D. Mayes .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this chapter

Cite this chapter

Salazar, G.A., Steen, V.D., Mayes, M.D. (2014). Systemic Sclerosis Mimics. In: Mayes, M. (eds) A Visual Guide to Scleroderma and Approach to Treatment. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-0980-3_9

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-0980-3_9

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-0979-7

  • Online ISBN: 978-1-4939-0980-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics